Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Leadership
Beverly Davidson
Founder
Katherine High
Founder
Financial Performance
Funding
Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2014
72.8M USD
Series A
2013
50M USD
Series A
Known Investors
Name
Type
HQ
Other Relevant Investments
Private Equity
United States
Foundation
United States
Private Equity
United States
Private Equity
United States
Venture Capital
United States
Investment Bank
United States
Investment Bank
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]
Related
News
News